CENP-U is part of the constitutive centromere-associated network (CCAN), a complex of proteins that are permanently associated with the centromere throughout the cell cycle. The CCAN is responsible for the assembly and maintenance of the kinetochore, a protein structure on the centromere that attaches chromosomes to the spindle fibers during cell division .
CENP-U interacts with other centromere proteins, such as CENP-C and CENP-H, to form a stable complex that is crucial for kinetochore function. This interaction ensures the proper attachment of spindle fibers to the centromere, facilitating the accurate segregation of chromosomes .
Recombinant CENP-U is produced using recombinant DNA technology, which involves inserting the gene encoding CENP-U into a suitable expression system, such as bacteria or yeast. This allows for the large-scale production of CENP-U for research and therapeutic purposes.
Recombinant CENP-U is used in various research applications, including the study of centromere and kinetochore function, the investigation of chromosome segregation mechanisms, and the development of potential therapeutic interventions for diseases related to chromosome missegregation .
Mutations or dysregulation of CENP-U and other centromere proteins can lead to chromosomal instability, which is a hallmark of many cancers. Understanding the role of CENP-U in chromosome segregation can provide insights into the mechanisms underlying chromosomal instability and potentially lead to the development of targeted therapies for cancer treatment .
Additionally, autoantibodies against centromere proteins, including CENP-U, are often found in patients with autoimmune diseases such as systemic sclerosis and primary biliary cholangitis. These autoantibodies can serve as diagnostic markers and provide insights into the pathogenesis of these diseases .